Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Board Change

5 Sep 2007 08:33

Quadnetics Group PLC05 September 2007 For Immediate Release 5 September 2007 Quadnetics Group plc Board Change Quadnetics has agreed to release David Orme, Group Operations Director to takeup a position as Chief Executive of a private, non-competing company based incontinental Europe. Mr Orme will be continuing in his current post, and as adirector of the Company, until a proper handover has been completed, expected tobe before the end of the current calendar year. Commenting on the move, Russ Singleton, Chief Executive, said: "In the two years David that has been with us he has been mainly focused onQuadrant Security Group, our services business, and played a key role in thesuccessful integration of the SDA Protec acquisition. The Board and I would liketo thank David for his efforts and wish him every success for his futurecareer". For further information, please contact:Quadnetics Group plc Tel: +44 (0) 1527 850080Russ Singleton, Chief ExecutiveEmail: russ.singleton@quadnetics.com www.quadnetics.com Brewin Dolphin Securities Tel: +44 (0) 113 241 0130Neil Baldwin Media enquiries:Buchanan Communications Limited Tel: +44 (0) 20 7466 5000Isabel PoddaEmail: isabelp@buchanan.uk.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th May 20114:14 pmRNSHolding(s) in Company
10th May 20119:53 amRNSHolding(s) in Company
5th May 20113:17 pmRNSResult of AGM
4th May 20117:00 amRNSAGM Statement
15th Apr 201110:00 amRNSHolding(s) in Company
8th Apr 20113:39 pmRNSDirector Shareholding
7th Apr 20117:00 amRNSAGM - Date Change
30th Mar 20114:35 pmRNSAvailability of Report & Accounts
8th Mar 20117:00 amRNSRe: 2009 Group Executive Shared Ownership Plan
4th Mar 20117:00 amRNSPreliminary Results
1st Feb 201111:06 amRNSNotification of Results
7th Jan 20114:02 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSAcquisition
21st Dec 201010:45 amRNSHolding(s) in Company
21st Dec 20107:00 amRNSHolding(s) in Company
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20107:00 amRNSPost Year End Trading Update
27th Jul 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSInterim Results
21st Jan 201010:36 amRNSContract Win
15th Jan 20102:59 pmRNSREPLACEMENT: Notice of Results
15th Jan 201010:35 amRNSNotice of Results
11th Nov 200910:59 amRNSResult of AGM
5th Nov 20097:00 amRNSTrading Update
9th Sep 20097:00 amRNSPreliminary Results
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.